Illumina releases SpliceAI2 to help advance rare disease research

Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic ...
Unite.AI

Illumina Launches SpliceAI2 Model for Splice Variant Interpretation

Illumina introduced SpliceAI2 on October 8, 2026, a genomic AI model from its BioInsight AI Lab that predicts how genetic ...
BIOENGINEER

Splice Variant VEGF165b Emerges as a Natural Shield Against Acute Lung Injury

A newly published study identifies the VEGF-A splice variant VEGF165b as an endogenous protector that shields the lung's ...
MarketScreener

Illumina, Inc. Introduces SpliceAI2 To Help Advance Rare Disease Research

Illumina, Inc. introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic variation. SpliceAI2 ...